Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
tPA-PAI complex assay |
Has measured component |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
Tissue plasminogen activator assay |
Has measured component |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
Tissue plasminogen activator activity assay |
Has measured component |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
Tissue plasminogen activator antigen assay |
Has measured component |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
Tissue plasminogen activator antigen |
Direct substance |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
tPA-PAI complex assay |
Component |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
2 |
Tissue plasminogen activator assay |
Component |
True |
Tissue plasminogen activator |
Inferred relationship |
Some |
1 |
Tissue plasminogen activator activity assay |
Component |
True |
Tissue plasminogen activator |
Inferred relationship |
Some |
1 |
Tissue plasminogen activator antigen assay |
Component |
True |
Tissue plasminogen activator |
Inferred relationship |
Some |
1 |
Reteplase (substance) |
Is a |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
Alteplase (substance) |
Is a |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
Tenecteplase (substance) |
Is a |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
Product containing tissue plasminogen activator (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tissue plasminogen activator |
Inferred relationship |
Some |
1 |
Product containing reteplase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
alteplase 50 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
alteplase 20 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
alteplase 10 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
reteplase 10 enheder pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
Product containing tenecteplase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
Product containing alteplase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
tenecteplase 8.000 IE (40 mg) pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
tenecteplase 10.000 IE (50 mg) injektionsvæske, opløsning, pulver og solvens i hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
alteplase 1 mg injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
Reteplase, recombinant 10unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
alteplase 100 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tissue plasminogen activator |
Inferred relationship |
Some |
|
Product containing only tissue plasminogen activator (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tissue plasminogen activator |
Inferred relationship |
Some |
1 |
Fibrinolytic disorder caused by tissue plasminogen activator |
Causative agent |
True |
Tissue plasminogen activator |
Inferred relationship |
Some |
2 |
Intravenous injection of tissue plasminogen activator (procedure) |
Direct substance |
True |
Tissue plasminogen activator |
Inferred relationship |
Some |
1 |
Intra-arterial injection of tissue plasminogen activator |
Direct substance |
True |
Tissue plasminogen activator |
Inferred relationship |
Some |
1 |
Adverse reaction caused by tissue plasminogen activator (disorder) |
Causative agent |
True |
Tissue plasminogen activator |
Inferred relationship |
Some |
1 |
tPA-PAI complex assay |
Component |
True |
Tissue plasminogen activator |
Inferred relationship |
Some |
1 |